NasdaqGS - Nasdaq Real Time Price USD
Absci Corporation (ABSI)
2.9100
-0.0500
(-1.69%)
At close: May 14 at 4:00:01 PM EDT
2.8100
-0.10
(-3.44%)
Pre-Market: 5:18:01 AM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 19.39M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| BUSCH ANDREAS Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
| MCCLAIN SEAN Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
| BEDRICK TODD Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
| JONASSON ZACHARIAH PH.D. Chairman of the Board | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
| WALKER SHELBY J Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
| JONASSON ZACHARIAH PH.D. Chairman of the Board | Sale at price 4.98 per share. | Direct | 98,892 | Jun 13, 2024 |
| JONASSON ZACHARIAH PH.D. Chairman of the Board | Conversion of Exercise of derivative security at price 3.39 per share. | Direct | 97,293 | Jun 13, 2024 |
| SIROSH JOSEPH Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 12, 2024 |
| MCGINNIS KAREN K Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 12, 2024 |
| REDMILE GROUP, L.L.C. Director | Stock Award(Grant) at price 0.00 per share. | Indirect | 0 | Jun 12, 2024 |
| NAGPAL AMRIT Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 12, 2024 |
| RABINOVITSJ DANIEL A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 12, 2024 |
| VAN HOUTEN VAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 12, 2024 |
| PANGALOS MENELAS N Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 12, 2024 |
| PHOENIX VENTURE PARTNERS II LP Beneficial Owner of more than 10% of a Class of Security | Sale at price 4.40 per share. | Indirect | 13,640,000 | May 22, 2024 |
| MCCLAIN SEAN Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 19, 2024 |
| REDMILE GROUP, L.L.C. Unknown | Purchase at price 4.50 per share. | Indirect | 999,999 | Mar 1, 2024 |
| BUSCH ANDREAS Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 1, 2024 |
| MCCLAIN SEAN Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 1, 2024 |
| BEDRICK TODD Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 1, 2024 |
| JONASSON ZACHARIAH PH.D. Chairman of the Board | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 1, 2024 |
| PHOENIX VENTURES PARTNERS II LP. Beneficial Owner of more than 10% of a Class of Security | Sale at price 1.40 - 1.44 per share. | Indirect | 161,884 | Nov 28, 2023 |
| BUSCH ANDREAS Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 12, 2023 |
| MCCLAIN SEAN Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 12, 2023 |
| BEDRICK TODD Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 12, 2023 |
| JONASSON ZACHARIAH PH.D. Chairman of the Board | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 12, 2023 |
| JONASSON ZACHARIAH PH.D. Chairman of the Board | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 1, 2023 |
Related Tickers
RXRX Recursion Pharmaceuticals, Inc.
4.3100
-4.43%
PRME Prime Medicine, Inc.
1.2100
-4.72%
XLO Xilio Therapeutics, Inc.
0.8500
-26.09%
CRVS Corvus Pharmaceuticals, Inc.
3.6200
-6.94%
CTMX CytomX Therapeutics, Inc.
2.3800
-4.80%
HUMA Humacyte, Inc.
1.8700
+8.09%
NTLA Intellia Therapeutics, Inc.
7.88
-5.29%
CNSP CNS Pharmaceuticals, Inc.
1.1500
-15.44%
ABCL AbCellera Biologics Inc.
2.0500
-2.38%
BEAM Beam Therapeutics Inc.
17.24
-4.49%